Programmed cell death mechanisms of traditional plant medicine in prostate cancer therapy

Yuchen Zhang1,2,3,4, Sheng Qin4, Yingping Wang2,3

  • 1Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.

Abstract

Insights

Traditional plant medicine (TPM) shows promise in treating prostate cancer (PCa) by inducing various programmed cell death (PCD) pathways. Further research is needed to clarify mechanisms for autophagy and pyroptosis in PCa treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Prostate cancer (PCa) remains a significant health concern with persistent challenges in treatment, necessitating novel therapeutic strategies.
  • Traditional Plant Medicine (TPM) is being investigated as a potential alternative therapy for PCa due to its ability to induce programmed cell death (PCD).
  • Existing reviews often focus on single PCD pathways, overlooking the simultaneous investigation of multiple PCD types like autophagy, apoptosis, pyroptosis, ferroptosis, and necroptosis in PCa.

Purpose of the Study:

  • To comprehensively review the role of Traditional Plant Medicine (TPM) in inducing various programmed cell death (PCD) pathways for prostate cancer (PCa) treatment.
  • To identify key molecular targets and signaling pathways involved in the anticancer effects of TPMs.
  • To highlight research gaps concerning the interplay between different PCD modalities and TPMs in PCa therapy.

Main Methods:

  • Systematic literature search across PubMed, Web of Science, and ScienceDirect databases for articles published within the last five years.
  • Keywords included "prostate cancer," "therapeutic," "traditional medicine," various PCD types (apoptosis, pyroptosis, autophagy, necroptosis, ferroptosis), "active ingredients," "Herbal," and signaling pathways.
  • Selection and screening of relevant articles based on the defined search strategy and inclusion criteria.

Main Results:

  • Forty-two TPMs demonstrated significant anticancer activity against PCa by modulating multiple PCD pathways.
  • Key molecular targets mediating TPM's anticancer effects include PI3K/AKT/mTOR, AMPK/mTOR, AKT1/Bcl2/NF-κB, GPBAR1/NF-κB, Keap1/Nrf2/ARE, and PINK1/Parkin signaling pathways.
  • Apoptosis, autophagy, and ferroptosis are well-researched, while pyroptosis and necroptosis are less explored. Interactions between PCD types are rarely investigated in depth.

Conclusions:

  • Traditional Plant Medicine (TPM) effectively targets prostate cancer (PCa) through the induction of apoptosis, ferroptosis, and necroptosis.
  • The precise mechanisms of TPM-induced autophagy and pyroptosis in PCa require further investigation.
  • Elucidating the role of PCD modulators is crucial for refining TPM-based therapeutic strategies for PCa.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...